These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 17627161

  • 21. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
    Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, Emami M, Daigneault L, Panchal C, Sugar L, Jewett MA, Narod SA.
    J Urol; 2006 Apr; 175(4):1291-7. PubMed ID: 16515983
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A, Rhoden EL.
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Is low serum free testosterone a marker for high grade prostate cancer?
    Hoffman MA, DeWolf WC, Morgentaler A.
    J Urol; 2000 Mar; 163(3):824-7. PubMed ID: 10687985
    [Abstract] [Full Text] [Related]

  • 25. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L, Costantini E, Zucchi A, Mearini E, Bini V, Cottini E, Porena M.
    Urol Int; 2008 Mar; 80(2):134-40. PubMed ID: 18362481
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 28. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer.
    Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM.
    J Urol; 2005 Dec; 174(6):2178-80. PubMed ID: 16280759
    [Abstract] [Full Text] [Related]

  • 29. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB, Ghimenton C, Petrozziello A, Sava T, Migliorini F, Romano M, Caruso B, Cocco C, Antoniolli SZ, Lacola V, Rubilotta E, Monaco C.
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [Abstract] [Full Text] [Related]

  • 30. Serum keratinocyte growth factor measurement in patients with prostate cancer.
    Mehta PB, Robson CN, Neal DE, Leung HY.
    J Urol; 2000 Dec; 164(6):2151-5. PubMed ID: 11061946
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI.
    Cancer; 2008 Nov 15; 113(10):2695-703. PubMed ID: 18853417
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
    Passadakis P, Ersoy F, Tam P, Memmos D, Siamopoulos K, Ozener C, Akçiçek F, Camsari T, Ates K, Ataman R, Vlachojannis J, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis C, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gültekin M, Karayalçin B, Challa A, Polat N, Oreopoulos DG.
    Adv Perit Dial; 2004 Nov 15; 20():203-8. PubMed ID: 15384827
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.
    Int J Urol; 2008 Jul 15; 15(7):598-603. PubMed ID: 18462353
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y.
    BJU Int; 2005 Jun 15; 95(9):1245-8. PubMed ID: 15892809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.